Skip to main content

Peer Review reports

From: ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial

Original Submission
19 Sep 2019 Submitted Original manuscript
10 Oct 2019 Author responded Author comments - Qingguo li
Resubmission - Version 2
10 Oct 2019 Submitted Manuscript version 2
Publishing
25 Oct 2019 Editorially accepted
15 Nov 2019 Article published 10.1186/s12885-019-6289-6

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us